Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Aug 6, 2007

MitoPharm Licenses New Extraction Method

  • MitoPharm signed an exclusive, worldwide licensing agreement with the Hong Kong University of Science and Technology for the use and commercialization of its patent-pending process for the extraction of (-) Schisandrin B and Schisandrin B.

    MitoPharm reports that it thus gains the first commercial-scale process for the extraction of Schisandrin B that delivers a high degree of purity and well-defined bacterial levels. The process incorporates hybrid chromatography, which is widely used in the fine chemical and pharmaceutical industries for the recovery of high-purity products.



Be sure to take the GEN Poll

CRISPR Patent Controversy

Do you think recently released email from a former Broad Institute scientist to Jennifer Doudna will expedite a final legal decision on who owns the CRISPR patent?

More »